BIOMAT Database Logo BIOMAT Database Logo

Acute myeloid leukemia arising after Hodgkin lymphoma in a patient with WHIM syndrome. 2019

Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
Department of Pediatric Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069439 Dasatinib A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide,BMS 354825,BMS-354825,BMS354825,N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide,Sprycel,354825, BMS
D000073659 Gain of Function Mutation A mutation that results in an increase in a gene's activity or in acquiring a new molecular function or a new pattern of gene expression. Activation Mutation,Activation Mutations,Mutation, Activation,Mutations, Activation

Related Publications

Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
Classical Hodgkin lymphoma arising in a patient with chronic lymphocytic leukemia (Richter syndrome).
November 2017, Blood,
Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
B-cell lymphoma in a patient with WHIM syndrome.
January 2001, Journal of the American Academy of Dermatology,
Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma.
July 2016, Future oncology (London, England),
Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
17p- syndrome arising from a novel dicentric translocation in a patient with acute myeloid leukemia.
April 2000, Cancer genetics and cytogenetics,
Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
A case of non-Hodgkin lymphoma in a patient with chronic myeloid leukemia.
January 2013, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
[A patient with acute non-lymphatic leukemia 2 years after non-Hodgkin lymphoma].
April 1988, Nederlands tijdschrift voor geneeskunde,
Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome.
April 2011, Cancer,
Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma.
April 2019, Cancer,
Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis.
January 2018, Case reports in hematology,
Aoli Zhang, and Xiaojuan Chen, and Zhanqi Li, and Min Ruan, and YingChi Zhang, and Xiaofan Zhu
Primary cutaneous follicle center lymphoma in a patient with WHIM syndrome.
March 2016, Journal of the European Academy of Dermatology and Venereology : JEADV,
Copied contents to your clipboard!